Urine-normetanephrine, a predictor of mortality risk in patients with adrenal adenomas
Abstract Urine-metanephrines are used in the screening for pheochromocytomas in patients with adrenal incidentalomas, but their potential as markers for mortality in patients with adrenal adenomas has not been studied. A retrospective cohort study was designed to investigate if urine-metanephrines w...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-04-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-94951-w |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849734789794365440 |
|---|---|
| author | Albin Kjellbom Magnus Löndahl Malin Danielsson Henrik Olsen Ola Lindgren |
| author_facet | Albin Kjellbom Magnus Löndahl Malin Danielsson Henrik Olsen Ola Lindgren |
| author_sort | Albin Kjellbom |
| collection | DOAJ |
| description | Abstract Urine-metanephrines are used in the screening for pheochromocytomas in patients with adrenal incidentalomas, but their potential as markers for mortality in patients with adrenal adenomas has not been studied. A retrospective cohort study was designed to investigate if urine-metanephrines were associated with mortality in patients with adrenal adenomas. Participants where consecutively included between 2005 and 2015 at two endocrine centres in southern Sweden and followed until December 31st, 2022. The exposures were 24 h-urine (tU) metanephrine and normetanephrine analysed at inclusion. The endpoint was all-cause mortality. Outcome data were obtained from the Cause of Death Register. 879 adult (≥ 18 years) patients with an incidentally discovered adrenal adenoma were included in the study and followed for a median of 9.9 years. Median age of patients was 66.7 years, and 59.6% were women. 278 patients died during follow-up. tU-normetanephrine was associated with increased mortality, adjusted hazard ratio (HR) 1.47 (95% CI, 1.27–1.69) (HR for an increase of 100 μmol/mol creatinine). There was no significant association between tU-metanephrine and mortality, HR 0.96 (0.64–1.43). tU-normetanephrine seems to be a predictor for mortality in patients with adrenal adenomas. This widely available diagnostic test may be helpful in further risk-stratifying patients with adrenal adenomas. |
| format | Article |
| id | doaj-art-835f6c554fb944109d5c09e57d0f00c5 |
| institution | DOAJ |
| issn | 2045-2322 |
| language | English |
| publishDate | 2025-04-01 |
| publisher | Nature Portfolio |
| record_format | Article |
| series | Scientific Reports |
| spelling | doaj-art-835f6c554fb944109d5c09e57d0f00c52025-08-20T03:07:41ZengNature PortfolioScientific Reports2045-23222025-04-011511910.1038/s41598-025-94951-wUrine-normetanephrine, a predictor of mortality risk in patients with adrenal adenomasAlbin Kjellbom0Magnus Löndahl1Malin Danielsson2Henrik Olsen3Ola Lindgren4Department of Clinical Sciences, Faculty of Medicine, Lund UniversityDepartment of Clinical Sciences, Faculty of Medicine, Lund UniversityDepartment of Clinical Sciences, Faculty of Medicine, Lund UniversityDepartment of Clinical Sciences, Faculty of Medicine, Lund UniversityDepartment of Clinical Sciences, Faculty of Medicine, Lund UniversityAbstract Urine-metanephrines are used in the screening for pheochromocytomas in patients with adrenal incidentalomas, but their potential as markers for mortality in patients with adrenal adenomas has not been studied. A retrospective cohort study was designed to investigate if urine-metanephrines were associated with mortality in patients with adrenal adenomas. Participants where consecutively included between 2005 and 2015 at two endocrine centres in southern Sweden and followed until December 31st, 2022. The exposures were 24 h-urine (tU) metanephrine and normetanephrine analysed at inclusion. The endpoint was all-cause mortality. Outcome data were obtained from the Cause of Death Register. 879 adult (≥ 18 years) patients with an incidentally discovered adrenal adenoma were included in the study and followed for a median of 9.9 years. Median age of patients was 66.7 years, and 59.6% were women. 278 patients died during follow-up. tU-normetanephrine was associated with increased mortality, adjusted hazard ratio (HR) 1.47 (95% CI, 1.27–1.69) (HR for an increase of 100 μmol/mol creatinine). There was no significant association between tU-metanephrine and mortality, HR 0.96 (0.64–1.43). tU-normetanephrine seems to be a predictor for mortality in patients with adrenal adenomas. This widely available diagnostic test may be helpful in further risk-stratifying patients with adrenal adenomas.https://doi.org/10.1038/s41598-025-94951-wAdrenal adenomaAdrenal incidentalomaCatecholaminesMetanephrines |
| spellingShingle | Albin Kjellbom Magnus Löndahl Malin Danielsson Henrik Olsen Ola Lindgren Urine-normetanephrine, a predictor of mortality risk in patients with adrenal adenomas Scientific Reports Adrenal adenoma Adrenal incidentaloma Catecholamines Metanephrines |
| title | Urine-normetanephrine, a predictor of mortality risk in patients with adrenal adenomas |
| title_full | Urine-normetanephrine, a predictor of mortality risk in patients with adrenal adenomas |
| title_fullStr | Urine-normetanephrine, a predictor of mortality risk in patients with adrenal adenomas |
| title_full_unstemmed | Urine-normetanephrine, a predictor of mortality risk in patients with adrenal adenomas |
| title_short | Urine-normetanephrine, a predictor of mortality risk in patients with adrenal adenomas |
| title_sort | urine normetanephrine a predictor of mortality risk in patients with adrenal adenomas |
| topic | Adrenal adenoma Adrenal incidentaloma Catecholamines Metanephrines |
| url | https://doi.org/10.1038/s41598-025-94951-w |
| work_keys_str_mv | AT albinkjellbom urinenormetanephrineapredictorofmortalityriskinpatientswithadrenaladenomas AT magnuslondahl urinenormetanephrineapredictorofmortalityriskinpatientswithadrenaladenomas AT malindanielsson urinenormetanephrineapredictorofmortalityriskinpatientswithadrenaladenomas AT henrikolsen urinenormetanephrineapredictorofmortalityriskinpatientswithadrenaladenomas AT olalindgren urinenormetanephrineapredictorofmortalityriskinpatientswithadrenaladenomas |